1,751 Shares in Intuitive Surgical, Inc. $ISRG Purchased by Syntax Research Inc.

Posted by Geri Gentry on Nov 10th, 2026

Syntax Research Inc. bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,751 shares of the medical equipment provider’s stock, valued at approximately $712,000. Intuitive Surgical accounts for approximately 0.5% of Syntax Research Inc.’s investment portfolio, making the stock its 27th biggest holding.

A number of other large investors also recently added to or reduced their stakes in ISRG. Bank of America Corp DE increased its position in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Intuitive Surgical in the second quarter valued at $1,335,753,000. Amundi boosted its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after purchasing an additional 184,044 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Revenue grew 22%, and the company placed 546 da Vinci systems in the third quarter of 2026. The article notes that system placements support a larger installed base, while instruments and services generate much of Intuitive Surgical’s recurring revenue. Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street’s Sell-Off Misses the Point.
Positive Sentiment: Robust procedure growth and adoption of the da Vinci 5 system have helped shares recover, according to a six-month review. ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
Neutral Sentiment: Intuitive Surgical appeared on a published list of top healthcare stocks following the midterm elections. The inclusion reflects investor interest in the sector, but is not a company-specific business development. Why Intuitive Surgical (ISRG) Just Cracked the Top 10 Best Healthcare Stocks List
Negative Sentiment: Growing competition, litigation costs and valuation concerns could weigh on the shares. One article also notes that ISRG remains down for the year despite strong revenue growth. Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ISRG. Barclays reissued an “overweight” rating and issued a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research report on Thursday, July 30th. UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, October 31st. Finally, Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a report on Friday, August 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

View Our Latest Stock Report on Intuitive Surgical

Intuitive Surgical Stock Up 1.7%

ISRG stock opened at $460.56 on Tuesday. The business has a 50 day moving average price of $411.69 and a 200 day moving average price of $431.58. The stock has a market cap of $159.65 billion, a price-to-earnings ratio of 55.69, a PEG ratio of 3.32 and a beta of 1.45. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s quarterly revenue was up 21.7% compared to the same quarter last year. During the same period in the prior year, the company posted $2.40 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Patricia Wadors sold 1,078 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $453.21, for a total transaction of $1,834,140.87. Following the completion of the transaction, the vice president owned 1,026 shares of the company’s stock, valued at approximately $464,993.46. The trade was a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 39,056 shares of company stock worth $17,585,864. 0.60% of the stock is owned by insiders.